CARK 发表于 2025-3-23 11:12:37

Submitted on: 06 November 2012.
Revised on: 01 January 2013.
Accepted on: 05 February 2013.

___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC

Common-Migraine 发表于 2025-3-23 14:37:20

http://reply.papertrans.cn/1/19/1845/1845-12.png

enumaerate 发表于 2025-3-23 19:22:58

http://reply.papertrans.cn/1/19/1845/1845-13.png

insomnia 发表于 2025-3-24 00:54:46

Submitted on: 22 March 2019.
Revised on: 01 May 2019.
Accepted on: 11 May 2019.

___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC

灌输 发表于 2025-3-24 02:51:30

http://reply.papertrans.cn/1/19/1845/1845-15.png

相同 发表于 2025-3-24 10:01:22

http://reply.papertrans.cn/1/19/1845/1845-16.png

PACK 发表于 2025-3-24 11:46:43

http://reply.papertrans.cn/1/19/1845/1845-17.png

无能力之人 发表于 2025-3-24 18:15:58

http://reply.papertrans.cn/1/19/1845/1845-18.png

Isolate 发表于 2025-3-24 19:14:16

Submitted on: 11 August 2009.
Revised on: 03 November 2009.
Accepted on: 23 December 2009.

___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC

evince 发表于 2025-3-24 23:51:32

http://reply.papertrans.cn/1/19/1845/1845-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊ANNALS OF PHARMACOTHERAPY 2024/2025影响因子:2.377 (ANN PHARMACOTHER) (1060-0280). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc